Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
cfDNA Pan-cancer
- Do you recommend pooling this control with a patient sample after library prep, before NGS?
- 456 variants are all in one tube, or subsets?
- What is your background cfDNA made from?
- How do you design the ctDNA/ variant list?
- The variant (COSM214499) is always high in 0% in NGS QC results, why?
- Can’t find indel or other hard to detect variants?
- Are these control oligos, RNA, what is in it/ components?
- For NGS QC, do you use target capture sequence for the 456 variants, or use a whole genome sequence?
- What is the molecular structure of the 3′ and 5′ termini?
- How do you perform quality control on the reference standards?
- What reagents (e.g, library prep) do you use for the liquid biopsy workflow?
- What are the kit configurations of the cfDNA standards?
- What do you recommend for starting input?
- Were the mutations in the standards confirmed by NGS as well, as with digital PCR as it says in the document?
- Recommendations for diluting the controls?
- Is your background cfDNA limited supply?
- Could there be some mutation ‘contaminants’ coming from the background DNA as well?
Do you recommend pooling this control with a patient sample after library prep, before NGS?
Once prepared into a library with indices, there are no issues with pooling this control with patient samples for simultaneous sequencing.
Still have questions? Contact Us
456 variants are all in one tube, or subsets?
All 456 variants are stored in one tube.
Still have questions? Contact Us
What is your background cfDNA made from?
The Twist wild-type background cfDNA mimic is cell-line-derived and treated with our proprietary method for closely mimicking the fragmentation profile of naturally occurring cfDNA, which is characterized by a sharp mononucleosomal peak and a secondary dinucleosomal peak.
Still have questions? Contact Us
How do you design the ctDNA/ variant list?
Twist performed a literature search to arrive at a list of curated, clinically-relevant (i.e. actionable) cancer-associated variants, as well as using the COSMIC database as a reference, where matching entries are available It includes the many prevalent variants in adult solid tumors. The 456 variants occur in 85 unique genes. Twist also separately annotates the set of clinical relevant variants (>140 of variants).
The configuration of variants and their precise reference and alternative sequence are listed on the Twist website.
Still have questions? Contact Us
The variant (COSM214499) is always high in 0% in NGS QC results, why?
This deletion occurs in the gene ATM at a genomic context with 10 consecutive Ts. These consecutive Ts makes the locus a "slippery" sequence, where the DNA polymerase replicating a copy of the genome can have the template strand slip relative to the strand being synthesized, leading to an INDEL.
The same effect has a high likelihood of occuring by the same mechanism when a PCR polymerase copies the sequence during library prep PCR. Thus, this locus is especially likely to spontaneously form the variant sequence due to PCR cycling during ordinary library prep.
When the allele is not present at all, any human genomic sample (including the Pan-cancer Reference Standard) will show an elevated VAF for this mutation due to PCR error. (In pan-cancer 0% VAF, it shows up at a higher VAF than 99.8% of other variant sites in the standard.) Thus, the background noise is higher due to the genomic context, meaning the Limit of Blank (LoB) of this variant is likely higher than other loci due to the sequence contest.
When the allele is present, the true allele frequency will be added “on top of” the noise level of the locus, meaning this variant will likely have a higher Limit of Detection (LoD) than other variant sites.
Using UMI adapters (like the Twist UMI Adapters) and running consensus collapse and/or duplex collapse can help decrease the noise at this locus due to PCR error in library prep.
Still have questions? Contact Us
Can’t find indel or other hard to detect variants?
The standard contains many difficult-to-detect variants, including structural variants and INDELS ranging from 1 bp to 30 bp. Detection of individual variants can depend on what aligner and alignment setting the customer is using. These hard to detect variants are for experienced customers using their pipeline. So just having an understanding of it. SNVs and small INDELs (e.g. 5 bp or smaller) are more straightforward for customers to detect.
Still have questions? Contact Us
Are these control oligos, RNA, what is in it/ components?
The Twist cfDNA controls are double stranded DNA. They are a mixture of synthetic “ctDNA” molecules designed and printed with Twist technology and spiked into the background cfDNA to form each specific VAF level.
Still have questions? Contact Us
For NGS QC, do you use target capture sequence for the 456 variants, or use a whole genome sequence?
Twist performs whole exome sequencing for the background cfDNA background and utilizes a target capture on the 5% material, in addition to a ddPCR on the intermediate VAFs.
Still have questions? Contact Us
What is the molecular structure of the 3′ and 5′ termini?
The variant fragments are blunt-ended, double-strand DNA molecules.
Twist has tested the material to be a suitable standard in non-fragmenting end-repair and A-tail ligation (ERAT) library preparation protocols, as well as in amplicon protocols, such as ddPCR and qPCR. The performance of the v2 Pan-cancer Reference Standard is similar to the v1, and to any other dsDNA input into library prep.
Still have questions? Contact Us
How do you perform quality control on the reference standards?
Twist runs target enrichment NGS on the 0% and 5% VAF to ensure non-detection and detection, respectively, at all variant sites. Additionally, six sites across all VAF levels are confirmed via ddPCR.
Still have questions? Contact Us
What reagents (e.g, library prep) do you use for the liquid biopsy workflow?
Cell-free DNA is generated in a highly specific biological process that yields a characteristic fragment length profile. Thus, we recommend preparing a library that does not change the size profile in any way: using the "Twist Mechanical Fragmentation Library Prep Kit" without any additional fragmentation treatment. Our library insert sizes look superb when we use that method. We have used Twist UMI adapters extensively on the cfDNA samples, and they work great for duplex consensus and getting good assessments of the mutation rates.
Still have questions? Contact Us
What are the kit configurations of the cfDNA standards?
The full kit contains 7. If an individual tube is 3 ug, it is a single tube. The 2 tubes 300 ng configuration has 2 tubes.
|
Part Number |
Description |
|
107576 |
Twist cfDNA Pan-Cancer Reference Standard v2 Set, 300 ng kit |
|
107577 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0% (WT), 3 ug |
|
107578 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.1%, 3 ug |
|
107579 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.25%, 3 ug |
|
107580 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.5%, 3 ug |
|
107581 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 1%, 3 ug |
|
107582 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 2%, 3 ug |
|
107583 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 5%, 3 ug |
|
107584 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0%, 600 ng |
|
107585 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.1%, 600 ng |
|
107586 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.25%,600 ng |
|
107587 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.5%, 600 ng |
|
107588 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 1%, 600 ng |
|
107589 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 2%, 600 ng |
|
107590 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 5%, 600 ng |
Still have questions? Contact Us
What do you recommend for starting input?
Twist recommends starting with 30 ng of starting input. 20-30 ng is a typical range for liquid biopsy assay.
Still have questions? Contact Us
Were the mutations in the standards confirmed by NGS as well, as with digital PCR as it says in the document?
All 456 variants are confirmed by NGS (for both 0% and 5% VAF), and the 0.1%, 0.25%, 0.5%, 1% and 2% are generated from a blending of 0% and 5% stocks. We selected a set of six representative and relevant variants across 0% to 5% VAFs for ddPCR, showing quantitative formulations and a continuous serial dilution.
Still have questions? Contact Us
Recommendations for diluting the controls?
Twist recommends using "Low-EDTA TE," which is 10 mM Tris pH 8, 0.1 mM EDTA. If EDTA must be avoided for compatibility with downstream steps, Qiagen Elution Buffer (10 mM Tris-HCl, pH 8) can be used.
Still have questions? Contact Us
Is your background cfDNA limited supply?
The Twist cfDNA is sourced from an immortalized cell line, which enables us to create large production lots with consistent lot to lot genotypes and performance.
Still have questions? Contact Us
Could there be some mutation ‘contaminants’ coming from the background DNA as well?
The Twist background cfDNA high-fidelity non-amplified DNA is derived from our proprietary fragmentation process, and we have observed an extremely low mutation rate compared to competitor material.
Still have questions? Contact Us
Do you recommend pooling this control with a patient sample after library prep, before NGS?
Once prepared into a library with indices, there are no issues with pooling this control with patient samples for simultaneous sequencing.
Still have questions? Contact Us
456 variants are all in one tube, or subsets?
All 456 variants are stored in one tube.
Still have questions? Contact Us
What is your background cfDNA made from?
The Twist wild-type background cfDNA mimic is cell-line-derived and treated with our proprietary method for closely mimicking the fragmentation profile of naturally occurring cfDNA, which is characterized by a sharp mononucleosomal peak and a secondary dinucleosomal peak.
Still have questions? Contact Us
How do you design the ctDNA/ variant list?
Twist performed a literature search to arrive at a list of curated, clinically-relevant (i.e. actionable) cancer-associated variants, as well as using the COSMIC database as a reference, where matching entries are available It includes the many prevalent variants in adult solid tumors. The 456 variants occur in 85 unique genes. Twist also separately annotates the set of clinical relevant variants (>140 of variants).
The configuration of variants and their precise reference and alternative sequence are listed on the Twist website.
Still have questions? Contact Us
The variant (COSM214499) is always high in 0% in NGS QC results, why?
This deletion occurs in the gene ATM at a genomic context with 10 consecutive Ts. These consecutive Ts makes the locus a "slippery" sequence, where the DNA polymerase replicating a copy of the genome can have the template strand slip relative to the strand being synthesized, leading to an INDEL.
The same effect has a high likelihood of occuring by the same mechanism when a PCR polymerase copies the sequence during library prep PCR. Thus, this locus is especially likely to spontaneously form the variant sequence due to PCR cycling during ordinary library prep.
When the allele is not present at all, any human genomic sample (including the Pan-cancer Reference Standard) will show an elevated VAF for this mutation due to PCR error. (In pan-cancer 0% VAF, it shows up at a higher VAF than 99.8% of other variant sites in the standard.) Thus, the background noise is higher due to the genomic context, meaning the Limit of Blank (LoB) of this variant is likely higher than other loci due to the sequence contest.
When the allele is present, the true allele frequency will be added “on top of” the noise level of the locus, meaning this variant will likely have a higher Limit of Detection (LoD) than other variant sites.
Using UMI adapters (like the Twist UMI Adapters) and running consensus collapse and/or duplex collapse can help decrease the noise at this locus due to PCR error in library prep.
Still have questions? Contact Us
Can’t find indel or other hard to detect variants?
The standard contains many difficult-to-detect variants, including structural variants and INDELS ranging from 1 bp to 30 bp. Detection of individual variants can depend on what aligner and alignment setting the customer is using. These hard to detect variants are for experienced customers using their pipeline. So just having an understanding of it. SNVs and small INDELs (e.g. 5 bp or smaller) are more straightforward for customers to detect.
Still have questions? Contact Us
Are these control oligos, RNA, what is in it/ components?
The Twist cfDNA controls are double stranded DNA. They are a mixture of synthetic “ctDNA” molecules designed and printed with Twist technology and spiked into the background cfDNA to form each specific VAF level.
Still have questions? Contact Us
For NGS QC, do you use target capture sequence for the 456 variants, or use a whole genome sequence?
Twist performs whole exome sequencing for the background cfDNA background and utilizes a target capture on the 5% material, in addition to a ddPCR on the intermediate VAFs.
Still have questions? Contact Us
What is the molecular structure of the 3′ and 5′ termini?
The variant fragments are blunt-ended, double-strand DNA molecules.
Twist has tested the material to be a suitable standard in non-fragmenting end-repair and A-tail ligation (ERAT) library preparation protocols, as well as in amplicon protocols, such as ddPCR and qPCR. The performance of the v2 Pan-cancer Reference Standard is similar to the v1, and to any other dsDNA input into library prep.
Still have questions? Contact Us
How do you perform quality control on the reference standards?
Twist runs target enrichment NGS on the 0% and 5% VAF to ensure non-detection and detection, respectively, at all variant sites. Additionally, six sites across all VAF levels are confirmed via ddPCR.
Still have questions? Contact Us
What reagents (e.g, library prep) do you use for the liquid biopsy workflow?
Cell-free DNA is generated in a highly specific biological process that yields a characteristic fragment length profile. Thus, we recommend preparing a library that does not change the size profile in any way: using the "Twist Mechanical Fragmentation Library Prep Kit" without any additional fragmentation treatment. Our library insert sizes look superb when we use that method. We have used Twist UMI adapters extensively on the cfDNA samples, and they work great for duplex consensus and getting good assessments of the mutation rates.
Still have questions? Contact Us
What are the kit configurations of the cfDNA standards?
The full kit contains 7. If an individual tube is 3 ug, it is a single tube. The 2 tubes 300 ng configuration has 2 tubes.
|
Part Number |
Description |
|
107576 |
Twist cfDNA Pan-Cancer Reference Standard v2 Set, 300 ng kit |
|
107577 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0% (WT), 3 ug |
|
107578 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.1%, 3 ug |
|
107579 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.25%, 3 ug |
|
107580 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.5%, 3 ug |
|
107581 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 1%, 3 ug |
|
107582 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 2%, 3 ug |
|
107583 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 5%, 3 ug |
|
107584 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0%, 600 ng |
|
107585 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.1%, 600 ng |
|
107586 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.25%,600 ng |
|
107587 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 0.5%, 600 ng |
|
107588 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 1%, 600 ng |
|
107589 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 2%, 600 ng |
|
107590 |
Twist cfDNA Pan-Cancer Reference Standard v2 VAF 5%, 600 ng |
Still have questions? Contact Us
What do you recommend for starting input?
Twist recommends starting with 30 ng of starting input. 20-30 ng is a typical range for liquid biopsy assay.
Still have questions? Contact Us
Were the mutations in the standards confirmed by NGS as well, as with digital PCR as it says in the document?
All 456 variants are confirmed by NGS (for both 0% and 5% VAF), and the 0.1%, 0.25%, 0.5%, 1% and 2% are generated from a blending of 0% and 5% stocks. We selected a set of six representative and relevant variants across 0% to 5% VAFs for ddPCR, showing quantitative formulations and a continuous serial dilution.
Still have questions? Contact Us
Recommendations for diluting the controls?
Twist recommends using "Low-EDTA TE," which is 10 mM Tris pH 8, 0.1 mM EDTA. If EDTA must be avoided for compatibility with downstream steps, Qiagen Elution Buffer (10 mM Tris-HCl, pH 8) can be used.
Still have questions? Contact Us
Is your background cfDNA limited supply?
The Twist cfDNA is sourced from an immortalized cell line, which enables us to create large production lots with consistent lot to lot genotypes and performance.
Still have questions? Contact Us
Could there be some mutation ‘contaminants’ coming from the background DNA as well?
The Twist background cfDNA high-fidelity non-amplified DNA is derived from our proprietary fragmentation process, and we have observed an extremely low mutation rate compared to competitor material.
Still have questions? Contact Us